Snowden Capital Advisors’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Snowden Capital Advisors’s Portfolio PHAS Stock Details PHAS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell
2022 Q3	$10K	Hold
2022 Q2	$36K	Buy
2022 Q1	$68K	Buy
2021 Q4	$75K	Buy
2021 Q3	$65.3K	Buy
2021 Q2	$74.4K	Hold
2021 Q1	$69.2K	Buy